On March 11, 2020, the World Health Organization (WHO) officially declared COVID-19 to be a pandemic. Countries have been in lockdown, border controls have been tightened and airlines have had their capacity to ship products reduced.
This global situation has had a large impact on the logistics platforms for all industries, particularly for biopharmaceutical companies.
Many companies in this industry rely on a freight forwarder or a specialty logistics company to plan, organise and ship their products.
With the restrictions imposed on logistics companies from COVID-19, how can a biopharmaceutical company ensure it can effectively and safely transport its often life-saving shipments to their end destination?